Showing results (2081-2090 of 2,189) with videos related to
Sort By:
Pageof 219
Plos One|April 22, 2025
Correction: Practice patterns on the management of secondary hyperparathyroidism in the United States: Results from a modified Delphi panelDavid E Henner, Beatrice Drambarean, Teresa M Gerbeling, et al.The American Journal of Gastroenterology|November 2, 2017
Low-Dose Linaclotide (72 μg) for Chronic Idiopathic Constipation: A 12-Week, Randomized, Double-Blind, Placebo-Controlled TrialPhilip Schoenfeld, Brian E Lacy, William D Chey, et al.Cell Host & Microbe|August 14, 2020
Human mAbs Broadly Protect against Arthritogenic Alphaviruses by Recognizing Conserved Elements of the Mxra8 Receptor-Binding SiteLaura A Powell, Andrew Miller, Julie M Fox, et al.The American Journal of Gastroenterology|September 19, 2012
A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationSatish Rao, Anthony J Lembo, Steven J Shiff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Rapid hematopoietic recovery after multicycle high-dose chemotherapy: enhancement of filgrastim-induced progenitor-cell mobilization by recombinant human stem-cell factorR L Basser, L B To, C G Begley, et al.Journal of the American Heart Association|March 30, 2016
Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk ModelRohit M Oemrawsingh, K Martijn Akkerhuis, Laura C Van Vark, et al.Plos One|June 23, 2012
Three linked vasculopathic processes characterize Kawasaki disease: a light and transmission electron microscopic studyJan Marc Orenstein, Stanford T Shulman, Linda M Fox, et al.American Heart Journal|March 24, 2022
Balance of benefit and risk of ticagrelor in patients with diabetes and stable coronary artery disease according to bleeding risk assessment with the CRUSADE score: Data from THEMIS and THEMIS PCIGregory Ducrocq, Deepak L Bhatt, Jane J Lee, et al.Immunity|December 21, 2010
The 2.5 Å structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentationLouise Scharf, Nan-Sheng Li, Andrew J Hawk, et al.British Medical Journal|November 6, 1976
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United KingdomC P Aber, N M Bass, C L Berry, et al.Pageof 219